WELLS PHARMA OF HOUSTON LLC

Wells Pharma of Houston LLC specializes in the manufacturing of sterile pharmaceutical preparations under Section 503B of the FDCA, with deep expertise in compounding high-risk, non-sterile, and sterile injectables for institutional use. The company’s technical capabilities include aseptic processing, formulation development, and end-product validation for complex drug delivery systems such as prefilled syringes and vial-based therapeutics. Their work involves strict adherence to USP <797> and <800> standards, GMP compliance, and chain-of-custody protocols for controlled substances, with demonstrated experience producing critical-care agents like norepinephrine and other specialty injectables used in military and veteran healthcare settings. Their ability to deliver customized, small-batch, high-purity pharmaceuticals under tight regulatory timelines distinguishes them as a trusted supplier for mission-critical medical needs. The contractor maintains a consistent relationship with the Department of Veterans Affairs, supplying compounded pharmaceuticals to VA medical centers and specialty pharmacies, and has also supported the Department of Defense with mission-specific injectables for naval and military medical facilities. These engagements reflect a pattern of delivering tailored, non-commercial formulations that meet unique clinical and logistical requirements in austere or high-acuity environments. Operating under NAICS 325412, Wells Pharma focuses exclusively on pharmaceutical preparation manufacturing, positioning itself as a niche provider of 503B outsourcing facilities that bridge the gap between traditional compounding pharmacies and large-scale manufacturers. Their market presence centers on serving federal healthcare systems requiring reliable access to non-commercial, single-dose, and multi-dose sterile products. As a 2L entity based in Houston, Texas, Wells Pharma operates as a privately held manufacturer without federal certifications such as 8(a), HUBZone, or SDVOSB. Their geographic footprint is anchored in Texas, with supply chain and distribution networks calibrated to serve federal medical installations across the southern and coastal U.S.